Please try another search
For the three months ended 30 April 2022, SanBio Co Ltd revenues was not reported. Net loss applicable to common stockholders decreased 63% to Y315.8M. Lower net loss reflects Foreign exchange gains increase from Y695.3M to Y2.73B (income), Interest Expense decrease of 37% to Y7.5M (expense), Other Non-Operating Income increase from Y36K to Y898K (income). Basic Earnings per Share excluding Extraordinary Items increased from -Y16.61 to -Y5.98.
Period Ending: | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 |
---|---|---|---|---|
Total Revenue | ||||
Gross Profit | ||||
Operating Income | -814.45 | -641 | -1623 | -1461 |
Net Income | -761.28 | -96 | -1161 | -626 |
Period Ending: | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 |
---|---|---|---|---|
Total Assets | 5047.29 | 4302 | 4875 | 5932 |
Total Liabilities | 2254.89 | 2424 | 2647 | 2092 |
Total Equity | 2792.4 | 1878 | 2228 | 3840 |
Period Ending: | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review